AgelessRx vs PlushCare
Two GLP-1 desks, one scoreboard. We put AgelessRx and PlushCare head-to-head on the published Brief Score — the same six factors, scored the same way.
AgelessRx
The verdict
AgelessRx takes this head-to-head.
AgelessRx scores 85 to 71 on our six-factor Brief Score — A longevity-leaning brand with one of the lowest tracked semaglutide stickers — but a thin disclosure on the rest.
That doesn't make PlushCare a bad call — it's best for readers who want virtual primary care that can also prescribe glp-1s. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| AgelessRx | PlushCare | |
|---|---|---|
| Brief Score | 85/100 (B) | 71/100 (C) |
| Semaglutide | $139/mo | From $149/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | From $399/mo (starting dose, compounded) |
| Coverage | Not disclosed | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
AgelessRx: Low tracked semaglutide sticker; tirzepatide price still undisclosed.
PlushCare: New to the tracker on 1 August 2026. The published line reads From $149/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.